Corneal epithelium reconstruction

"Corneal epithelium reconstruction" refers to the restoration of the corneal epithelial tissue, often following injury, disease, or surgical intervention. The process relies on migration, proliferation, and differentiation of corneal epithelial cells as well as the regenerative function of limbal epithelial stem cells (LSCs) residing at the limbus (corneal border)[2][3][5]. Key molecular players and pathways involved include growth factors (e.g., insulin-like growth factor-1 (IGF-1), epidermal growth factor, fibroblast growth factor), various transcription factors (SOX2, p63, Pax6), exosomal and paracrine signaling, and involvement of mesenchymal stem cells or tissue-engineered scaffolds[1][3][5]. The loss or dysfunction of LSCs leads to impaired healing and chronic corneal defects. Corneal epithelium reconstruction is not a molecular therapeutic target but rather a clinical/regeneration endpoint supported by cellular and molecular interventions aimed at restoring ocular surface integrity and function[1][2][3][5]. Summary: - Corneal epithelium reconstruction is a **biological/regenerative process**, not a discrete molecular target or receptor. - The process involves multiple **cell types** (notably limbal epithelial stem cells), **growth factors**, **transcription factors**, and **cell migration/proliferation** pathways[1][3][5]. - Does **not** map to any single molecule, canonical abbreviation, or target classification—rather, it represents a tissue engineering/repair goal. - If you want structured information for therapeutic targets involved in this process, consider specifying molecules such as **Insulin-like growth factor 1 receptor (IGF-1R)**, **Epidermal growth factor receptor (EGFR)**, or markers for limbal stem cells[1][3].

Other names

Corneal epithelial repairCorneal epithelial regenerationCorneal wound healingCorneal epithelial reconstruction

Not applicable; see below for pathways and molecular mechanisms involved